Skip to main content

Curtis Oltmans

Equibles does not estimate personal net worth.

Get an email with a short summary when Avenue Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ATXI alerts

About Curtis Oltmans

Curtis Oltmans is recorded as Board Member at Avenue Therapeutics, Inc. (ATXI) since January 1, 2021. The newest filing on record that lists Curtis Oltmans as Board Member at Avenue Therapeutics, Inc. (ATXI) is dated December 5, 2025. Avenue Therapeutics, Inc. reported in an 8-K filed June 26, 2024 a re-election or new board role (Director) for Curtis Oltmans, on the board since at least 2021, effective June 24, 2024. Avenue Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avenue Therapeutics, Inc. includes Alexandra MacLean (CEO and Board Member), Alexandra MacLean, M.D. (CEO and Board Member), Jay Kranzler, M.D., Ph.D. (Chairman and Board Member) and 7 others.

“the election of six directors to hold office until the 2025 annual meeting of stockholders”
Avenue Therapeutics, Inc. Form 8-K, filed June 26, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Avenue Therapeutics, Inc.

Recent activity